Security
Basel Medical Group Ltd Ordinary Shares · BMGL
BMGLNASDAQCommon stockCurrentCIK 2004489Updated Oct 14, 2026
BMGL price & chart
Loading TradingView…
NASDAQ:BMGL on TradingView ↗About the company
Basel Medical is a BVI business company incorporated on August 10, 2023 with operations conducted by our subsidiaries based in Singapore. Our doctor-founder started practicing in Singapore in 2001 as a sole proprietor, when our first clinic was set up, and our first subsidiary, SSO Clinic, was incorporated in 2004. From 2004 to the 2020s, we expanded our operations and incorporated further operating entities in Singapore.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
cash flow · annual statements
| Line item | FY 2025 |
|---|---|
| Cash flows from operating activities: | |
| Profit or LossUSD | -8,362,433Source |
| Additional Financial Items | |
| AdjustmentsForDecreaseIncreaseInTradeAccountReceivableUSD | -6,830,279Source |
| AdjustmentsForIncreaseDecreaseInTradeAccountPayableUSD | -3,171,245Source |
| GoodwillSGD | 10,349,250Source |
| IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesUSD | 509,704Source |
| InterestPaidClassifiedAsOperatingActivitiesUSD | 160,349Source |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesUSD | 1,039,075Source |
| RepaymentsOfBorrowingsClassifiedAsFinancingActivitiesUSD | 6,495,235Source |
income statement · annual statements
| Line item | FY 2025 |
|---|---|
| Total RevenueUSD | 8,900,027Source |
| Additional Financial Items | |
| ApplicableTaxRatenumber | 0.17Source |
| BasicEarningsLossPerShareUSD per share | -0.45Source |
| DepreciationRightofuseAssetsUSD | 843,989Source |
| DilutedEarningsLossPerShareUSD per share | -0.45Source |
| EmployeeBenefitsExpenseUSD | 5,030,217Source |
| FinanceCostsUSD | 160,349Source |
| IncomeTaxExpenseContinuingOperationsUSD | -328,165Source |
| InterestExpenseOnLeaseLiabilitiesUSD | 90,389Source |
| OtherIncomeUSD | 1,225,864Source |
| OtherOperatingIncomeExpenseUSD | -2,594,707Source |
| ProfessionalFeesExpenseUSD | 191,393Source |
| ProfitLossAttributableToNoncontrollingInterestsUSD | -394Source |
| ProfitLossAttributableToOwnersOfParentUSD | -8,362,039Source |
| ProfitLossBeforeTaxUSD | -8,690,598Source |
| RevenueFromInterestUSD | 63,959Source |
Offerings
Registration 333-298988
- Gross proceeds
- 7980000.0
- Net proceeds
- 7501200.0
- Deal price
- 1.33
- Shares
- 6000000
- Offering price
- $1.33
- Ticker
- BMGL
Registration 333-282096
- Gross proceeds
- 10143000.0
- Net proceeds
- 9432990.0
- Deal price
- 4.0
- Shares
- 2535750
- Offering price
- $4.00
- Ticker
- BMGL
Filing attachments
ex4-1.htm · 6-K · 2026-10-13
Exhibit 4.1 FORM OF COMMON WARRANT BASEL MEDICAL GROUP LTD Warrant Issue Shares: [*] Date: [*], 2026 THIS COMMON WARRANT (this “ Warrant ”) certifies that, for value received, [*] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (the “ Initial Exercise Date ”) and on or prior to 5:00 p.m. (New York City time) on a date that is five (5) years …
Read attachment ↗ex99-1.htm · 6-K · 2026-10-13
Exhibit 99.1 Basel Medical Group Ltd (BMGL) Closes Registered Direct Offering Singapore, October 9, 2026 (GLOBE NEWSWIRE) - Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today closed its registered direct offering of 6,000,000 units, raising gross proceeds of US$7.98 million and estimated net proceeds of approximately US$7.28 million. The Company intends to use all of the net proceeds from this offering for general working capital purposes, mergers and acquisitions and other general c…
Read attachment ↗ex4-1.htm · 6-K · 2026-10-09
Exhibit 4.1 PLACEMENT AGENCY AGREEMENT October 7, 2026 Basel Medical Group Ltd 6 Napier Road, Unit #02-10/11 Gleneagles Medical Centre Singapore 258499 Ladies and Gentlemen: Subject to the terms and conditions herein (this “ Agreement ”), Basel Medical Group Ltd, a British Virgin Islands business company (the “ Company ”), hereby agrees to sell an aggregate of up to 6,000,000 units of the Company (the “ Units ”), each Unit consisting of (i) one ordinary share, no par value per share (“ O…
Read attachment ↗ex4-2.htm · 6-K · 2026-10-09
Exhibit 4.2 FORM OF COMMON WARRANT BASEL MEDICAL GROUP LTD Warrant Issue Shares: [*] Date: [*], 2026 THIS COMMON WARRANT (this “ Warrant ”) certifies that, for value received, [*] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (the “ Initial Exercise Date ”) and on or prior to 5:00 p.m. (New York City time) on a date that is five (5) years …
Read attachment ↗ex4-3.htm · 6-K · 2026-10-09
Exhibit 4.3 FORM OF PRE-FUNDED WARRANT Basel Medical Group Ltd Warrant Issue Shares: [*] Date: [*] ────────────────────────────── THIS PRE-FUNDED WARRANT (this “ Warrant ”) certifies that, for value received, [*] or its assigns (the “ Holder ”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “ Initial Exercise Date ”) and until this Warrant is exercised in full (t…
Read attachment ↗ex4-4.htm · 6-K · 2026-10-09
Exhibit 4.4 SECURITIES PURCHASE AGREEMENT THIS SECURITIES PURCHASE AGREEMENT (this “ Agreement ”) is entered into and made effective as of October 7, 2026, by and between Basel Medical Group Ltd, a British Virgin Islands business company (the “ Company ”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “ Purchaser ” and collectively the “ Purchasers ”). RECITALS WHEREAS, subject to the terms and conditions set forth in this Agreemen…
Read attachment ↗